As we have identified elevated CRP and GlycA to be predictive of future anxiety disorder diagnosis, further research is warranted to assess whether the prophylactic use of anti-inflammatory drugs is associated with a reduced risk of anxiety disorder onset. Here, CRP is linked to anxiety disorder.